Literature DB >> 25361414

Acquired drug resistance because of pharmacokinetic variability in a young child with tuberculosis.

Jotam G Pasipanodya1, Shashikant Srivastava, Tawanda Gumbo.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 25361414     DOI： 10.1097/INF.0000000000000436

Source DB:  PubMed          Journal:  Pediatr Infect Dis J        ISSN： 0891-3668            Impact factor:   2.129


× No keyword cloud information.
  3 in total

1.  Azithromycin Dose To Maximize Efficacy and Suppress Acquired Drug Resistance in Pulmonary Mycobacterium avium Disease.

Authors:  Devyani Deshpande; Jotam G Pasipanodya; Tawanda Gumbo
Journal:  Antimicrob Agents Chemother       Date:  2016-03-25       Impact factor: 5.191

Review 2.  Drug permeation and metabolism in Mycobacterium tuberculosis: Prioritising local exposure as essential criterion in new TB drug development.

Authors:  Lloyd Tanner; Paolo Denti; Lubbe Wiesner; Digby F Warner
Journal:  IUBMB Life       Date:  2018-06-22       Impact factor: 3.885

3.  Machine learning reveals that Mycobacterium tuberculosis genotypes and anatomic disease site impacts drug resistance and disease transmission among patients with proven extra-pulmonary tuberculosis.

Authors:  Doctor B Sibandze; Beki T Magazi; Lesibana A Malinga; Nontuthuko E Maningi; Bong-Akee Shey; Jotam G Pasipanodya; Nontombi N Mbelle
Journal:  BMC Infect Dis       Date:  2020-07-31       Impact factor: 3.090
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.